Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supreme Court To Hear Generic Drug Preemption Cases Against Advice Of Solicitor General

This article was originally published in The Pink Sheet Daily

Executive Summary

The court agreed to review three cases in which generic manufacturers of Reglan (metoclopramide) were held responsible for warning about the risk of tardive dyskinesia.

You may also be interested in...



Generic Industry Faces Uphill Battle In Preemption Case Before Supreme Court

Generic companies appear to be the underdogs as they head to the Supreme Court to argue they should not be held liable for inadequate label warnings.

Generic Industry Faces Uphill Battle In Preemption Case Before Supreme Court

Generic companies appear to be the underdogs as they head to the Supreme Court to argue they should not be held liable for inadequate label warnings.

High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption

The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.

Related Content

Topics

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel